15.49 USD
+0.09 (+0.58%)
Last: Feb 4, 2026, 12:42 PM
Overall SLP gets a fundamental rating of 6 out of 10. We evaluated SLP against 35 industry peers in the Health Care Technology industry. While SLP has a great health rating, its profitability is only average at the moment. SLP is showing excellent growth while it is valued at reasonable prices. Keep and eye on this one!
1. Profitability
1.1 Basic Checks
- SLP had positive earnings in the past year.
- SLP had a positive operating cash flow in the past year.
- Of the past 5 years SLP 4 years were profitable.
- SLP had a positive operating cash flow in each of the past 5 years.
1.2 Ratios
- With a Return On Assets value of -46.61%, SLP is not doing good in the industry: 68.57% of the companies in the same industry are doing better.
- With a Return On Equity value of -50.54%, SLP perfoms like the industry average, outperforming 48.57% of the companies in the same industry.
- The Return On Invested Capital of SLP (4.45%) is better than 74.29% of its industry peers.
- The Average Return On Invested Capital over the past 3 years for SLP is below the industry average of 6.63%.
- The 3 year average ROIC (3.61%) for SLP is below the current ROIC(4.45%), indicating increased profibility in the last year.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROIC | 4.45% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
1.3 Margins
- SLP's Operating Margin of 9.00% is amongst the best of the industry. SLP outperforms 82.86% of its industry peers.
- In the last couple of years the Operating Margin of SLP has declined.
- With a Gross Margin value of 59.60%, SLP perfoms like the industry average, outperforming 51.43% of the companies in the same industry.
- SLP's Gross Margin has declined in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% |
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
2. Health
2.1 Basic Checks
- With a Return on Invested Capital (ROIC) below the Cost of Capital (WACC), SLP is destroying value.
- Compared to 1 year ago, SLP has more shares outstanding
- Compared to 5 years ago, SLP has more shares outstanding
- SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
2.2 Solvency
- An Altman-Z score of 18.18 indicates that SLP is not in any danger for bankruptcy at the moment.
- SLP has a better Altman-Z score (18.18) than 91.43% of its industry peers.
- SLP has no outstanding debt. Therefor its Debt/Equity and Debt/FCF ratios are 0 and belong to the best of the industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Altman-Z | 18.18 |
ROIC/WACC0.46
WACC9.58%
2.3 Liquidity
- A Current Ratio of 5.62 indicates that SLP has no problem at all paying its short term obligations.
- SLP has a better Current ratio (5.62) than 85.71% of its industry peers.
- A Quick Ratio of 5.62 indicates that SLP has no problem at all paying its short term obligations.
- The Quick ratio of SLP (5.62) is better than 85.71% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 |
3. Growth
3.1 Past
- The Earnings Per Share has grown by an impressive 50.00% over the past year.
- Measured over the past 5 years, SLP shows a small growth in Earnings Per Share. The EPS has been growing by 1.07% on average per year.
- Looking at the last year, SLP shows a small growth in Revenue. The Revenue has grown by 5.69% in the last year.
- The Revenue has been growing by 13.74% on average over the past years. This is quite good.
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
3.2 Future
- Based on estimates for the next years, SLP will show a very strong growth in Earnings Per Share. The EPS will grow by 22.12% on average per year.
- The Revenue is expected to grow by 10.39% on average over the next years. This is quite good.
EPS Next Y-4.66%
EPS Next 2Y7.85%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
3.3 Evolution
- The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
- The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
- SLP is valuated quite expensively with a Price/Earnings ratio of 25.82.
- 74.29% of the companies in the same industry are more expensive than SLP, based on the Price/Earnings ratio.
- When comparing the Price/Earnings ratio of SLP to the average of the S&P500 Index (28.18), we can say SLP is valued inline with the index average.
- Based on the Price/Forward Earnings ratio of 22.96, the valuation of SLP can be described as rather expensive.
- Based on the Price/Forward Earnings ratio, SLP is valued a bit cheaper than 65.71% of the companies in the same industry.
- When comparing the Price/Forward Earnings ratio of SLP to the average of the S&P500 Index (25.51), we can say SLP is valued inline with the index average.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.82 | ||
| Fwd PE | 22.96 |
4.2 Price Multiples
- Based on the Enterprise Value to EBITDA ratio, SLP is valued a bit cheaper than the industry average as 65.71% of the companies are valued more expensively.
- Based on the Price/Free Cash Flow ratio, SLP is valued cheaper than 82.86% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 15.66 | ||
| EV/EBITDA | 18.72 |
4.3 Compensation for Growth
PEG (NY)N/A
PEG (5Y)24.18
EPS Next 2Y7.85%
EPS Next 3Y2.03%
5. Dividend
5.1 Amount
- With a yearly dividend of 0.61%, SLP is not a good candidate for dividend investing.
- Compared to an average industry Dividend Yield of 0.60, SLP pays a better dividend. On top of this SLP pays more dividend than 94.29% of the companies listed in the same industry.
- With a Dividend Yield of 0.61, SLP pays less dividend than the S&P500 average, which is at 1.83.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
5.2 History
- SLP has been paying a dividend for at least 10 years, so it has a reliable track record.
Dividend Growth(5Y)N/A
Div Incr Years0
Div Non Decr Years0
5.3 Sustainability
DP0%
EPS Next 2Y7.85%
EPS Next 3Y2.03%
NASDAQ:SLP (2/4/2026, 12:42:09 PM)
15.49
+0.09 (+0.58%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Technology
Earnings (Last)01-08 2026-01-08/amc
Earnings (Next)04-01 2026-04-01
Inst Owners79.38%
Inst Owner Change-5.52%
Ins Owners17.2%
Ins Owner Change-0.32%
Market Cap311.97M
Revenue(TTM)78.68M
Net Income(TTM)-64.25M
Analysts80
Price Target24.23 (56.42%)
Short Float %6.83%
Short Ratio3.14
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 0.61% |
Yearly Dividend0
Dividend Growth(5Y)N/A
DP0%
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)1
Avg EPS beat(2)-18.28%
Min EPS beat(2)-77.15%
Max EPS beat(2)40.59%
EPS beat(4)3
Avg EPS beat(4)71.31%
Min EPS beat(4)-77.15%
Max EPS beat(4)321.12%
EPS beat(8)4
Avg EPS beat(8)23.48%
EPS beat(12)5
Avg EPS beat(12)8.75%
EPS beat(16)7
Avg EPS beat(16)5.82%
Revenue beat(2)2
Avg Revenue beat(2)1.06%
Min Revenue beat(2)0.77%
Max Revenue beat(2)1.36%
Revenue beat(4)4
Avg Revenue beat(4)1.01%
Min Revenue beat(4)0.63%
Max Revenue beat(4)1.36%
Revenue beat(8)6
Avg Revenue beat(8)0.57%
Revenue beat(12)7
Avg Revenue beat(12)-0.44%
Revenue beat(16)10
Avg Revenue beat(16)0.08%
PT rev (1m)3.26%
PT rev (3m)3.26%
EPS NQ rev (1m)-19.39%
EPS NQ rev (3m)33.9%
EPS NY rev (1m)-27.96%
EPS NY rev (3m)34.19%
Revenue NQ rev (1m)2.05%
Revenue NQ rev (3m)-1.2%
Revenue NY rev (1m)0.21%
Revenue NY rev (3m)0.12%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 25.82 | ||
| Fwd PE | 22.96 | ||
| P/S | 3.97 | ||
| P/FCF | 15.66 | ||
| P/OCF | 13.2 | ||
| P/B | 2.45 | ||
| P/tB | 5.71 | ||
| EV/EBITDA | 18.72 |
EPS(TTM)0.6
EY3.87%
EPS(NY)0.67
Fwd EY4.36%
FCF(TTM)0.99
FCFY6.39%
OCF(TTM)1.17
OCFY7.58%
SpS3.91
BVpS6.31
TBVpS2.71
PEG (NY)N/A
PEG (5Y)24.18
Graham Number9.23
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -46.61% | ||
| ROE | -50.54% | ||
| ROCE | 5.55% | ||
| ROIC | 4.45% | ||
| ROICexc | 6.18% | ||
| ROICexgc | 29.44% | ||
| OM | 9% | ||
| PM (TTM) | N/A | ||
| GM | 59.6% | ||
| FCFM | 25.32% |
ROA(3y)-12.88%
ROA(5y)-5.32%
ROE(3y)-13.51%
ROE(5y)-5.53%
ROIC(3y)3.61%
ROIC(5y)4.56%
ROICexc(3y)6.84%
ROICexc(5y)12.7%
ROICexgc(3y)60.47%
ROICexgc(5y)79.01%
ROCE(3y)4.51%
ROCE(5y)5.69%
ROICexgc growth 3Y-33.77%
ROICexgc growth 5Y-24.05%
ROICexc growth 3Y-37.37%
ROICexc growth 5Y-22.33%
OM growth 3Y-33.32%
OM growth 5Y-21.72%
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-9.94%
GM growth 5Y-4.73%
F-Score6
Asset Turnover0.57
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0 | ||
| Debt/FCF | 0 | ||
| Debt/EBITDA | 0 | ||
| Cap/Depr | 50.91% | ||
| Cap/Sales | 4.72% | ||
| Interest Coverage | 250 | ||
| Cash Conversion | 164.46% | ||
| Profit Quality | N/A | ||
| Current Ratio | 5.62 | ||
| Quick Ratio | 5.62 | ||
| Altman-Z | 18.18 |
F-Score6
WACC9.58%
ROIC/WACC0.46
Cap/Depr(3y)77.49%
Cap/Depr(5y)94.25%
Cap/Sales(3y)6%
Cap/Sales(5y)7.05%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)50%
EPS 3Y-1.12%
EPS 5Y1.07%
EPS Q2Q%200%
EPS Next Y-4.66%
EPS Next 2Y7.85%
EPS Next 3Y2.03%
EPS Next 5Y22.12%
Revenue 1Y (TTM)5.69%
Revenue growth 3Y13.67%
Revenue growth 5Y13.74%
Sales Q2Q%-2.66%
Revenue Next Year2.12%
Revenue Next 2Y4.05%
Revenue Next 3Y5.79%
Revenue Next 5Y10.39%
EBIT growth 1Y33.64%
EBIT growth 3Y-24.21%
EBIT growth 5Y-10.96%
EBIT Next Year143.82%
EBIT Next 3Y43.31%
EBIT Next 5Y28.01%
FCF growth 1Y53.44%
FCF growth 3Y1.12%
FCF growth 5Y11.57%
OCF growth 1Y36.52%
OCF growth 3Y0.42%
OCF growth 5Y10.69%
SIMULATIONS PLUS INC / SLP FAQ
What is the ChartMill fundamental rating of SIMULATIONS PLUS INC (SLP) stock?
ChartMill assigns a fundamental rating of 6 / 10 to SLP.
Can you provide the valuation status for SIMULATIONS PLUS INC?
ChartMill assigns a valuation rating of 4 / 10 to SIMULATIONS PLUS INC (SLP). This can be considered as Fairly Valued.
How profitable is SIMULATIONS PLUS INC (SLP) stock?
SIMULATIONS PLUS INC (SLP) has a profitability rating of 4 / 10.
What is the financial health of SIMULATIONS PLUS INC (SLP) stock?
The financial health rating of SIMULATIONS PLUS INC (SLP) is 8 / 10.
Can you provide the expected EPS growth for SLP stock?
The Earnings per Share (EPS) of SIMULATIONS PLUS INC (SLP) is expected to decline by -4.66% in the next year.